Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
GUTS Fractyl Health Inc.
- Stocks
- Healthcare
- NASDAQ: GUTS
Price (delayed)
$1.6
Market cap
$78.36M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.86
Enterprise value
$97.68M
We are a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. Despite advances in treatment over the last
Highlights
GUTS's gross margin is up by 30% year-on-year and by 4.5% since the previous quarter
The EPS has surged by 95% year-on-year but it has declined by 15% since the previous quarter
Fractyl Health's equity has plunged by 92% YoY and by 78% from the previous quarter
GUTS's quick ratio has dropped by 76% year-on-year and by 34% since the previous quarter
Key stats
What are the main financial stats of GUTS
Market
Valuations
Earnings
Shares outstanding
48.98M
Market cap
$78.36M
Enterprise value
$97.68M
Price to earnings (P/E)
N/A
Price to book (P/B)
12.28
Price to sales (P/S)
1,303.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1,627.99
Revenue
$60,000
Gross profit
$29,000
Operating income
-$96.75M
Net income
-$89.11M
EBIT
-$89.11M
EBITDA
-$86.61M
Free cash flow
-$80.04M
Per share
Balance sheet
Liquidity
EPS
-$1.86
EPS diluted
-$1.86
Free cash flow per share
-$1.64
Book value per share
$0.13
Revenue per share
$0
TBVPS
$1.7
Total assets
$83.04M
Total liabilities
$76.67M
Debt
$61.43M
Equity
$6.38M
Working capital
$28.24M
Debt to equity
9.64
Current ratio
2.5
Quick ratio
2.24
Net debt/EBITDA
-0.22
Margins
Efficiency
Dividend
EBITDA margin
-144,351.7%
Gross margin
48.3%
Net margin
-148,511.7%
Operating margin
-161,246.7%
Return on assets
-76.7%
Return on equity
-228.7%
Return on invested capital
-102.7%
Return on capital employed
-138.7%
Return on sales
-148,511.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GUTS stock price
How has the Fractyl Health stock price performed over time
Intraday
-1.23%
1 week
-5.88%
1 month
-15.79%
1 year
-64.13%
YTD
-22.33%
QTD
-1.23%
Financial performance
How have Fractyl Health's revenue and profit performed over time
Revenue
$60,000
Gross profit
$29,000
Operating income
-$96.75M
Net income
-$89.11M
Gross margin
48.3%
Net margin
-148,511.7%
GUTS's net margin has dropped by 101% since the previous quarter
The company's operating income has shrunk by 61% YoY and by 3.4% QoQ
The operating margin has dropped by 60% since the previous quarter
The revenue has dropped by 59% year-on-year and by 35% since the previous quarter
Price vs fundamentals
How does GUTS's price correlate with its fundamentals
Growth
What is Fractyl Health's growth rate over time
Valuation
What is Fractyl Health stock price valuation
P/E
N/A
P/B
12.28
P/S
1,303.08
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1,627.99
The EPS has surged by 95% year-on-year but it has declined by 15% since the previous quarter
GUTS's P/B is 176% above its last 4 quarters average of 4.5
Fractyl Health's equity has plunged by 92% YoY and by 78% from the previous quarter
The revenue has dropped by 59% year-on-year and by 35% since the previous quarter
The price to sales (P/S) is 8% higher than the last 4 quarters average of 1225.9
Efficiency
How efficient is Fractyl Health business performance
Fractyl Health's ROE has plunged by 131% YoY and by 90% from the previous quarter
The return on sales has dropped by 101% since the previous quarter
The ROA has plunged by 51% YoY and by 48% from the previous quarter
GUTS's return on invested capital is down by 34% year-on-year and by 32% since the previous quarter
Dividends
What is GUTS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GUTS.
Financial health
How did Fractyl Health financials performed over time
Fractyl Health's total assets is 8% higher than its total liabilities
GUTS's quick ratio has dropped by 76% year-on-year and by 34% since the previous quarter
The current ratio has shrunk by 73% YoY and by 31% QoQ
Fractyl Health's equity has plunged by 92% YoY and by 78% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.